“With a weakened Iran and no nuclear capabilities, there is a growing view from tech investors that the opportunity for the ...

Calamos Global Convertible Fund posted a gain of 1.80% (Class I shares at NAV) during the first quarter, outperforming the ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Moderated discussion with founding physician of the Brain Tumor Center and Director of Neuro-Oncology at Piedmont Atlanta Hospital, Dr. Erin Dunbar HOUSTON, TX / ACCESS Newswire / June 24, 2025 / CNS ...

Discover how U.S. military action in Iran is intensifying tensions, impacting global oil supply, surging tanker rates, & ...